[HLFG] QoQ Quarter Result on 31-Dec-2017 [#2]

Stock
[HLFG] HONG LEONG FINANCIAL GROUP BHD
Announcement Date
26-Feb-2018
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2018
Quarter
31-Dec-2017 [#2]
Profit Trend
QoQ- 8.81%
YoY- 11.81%
Quarter Report
Latest QR
Upcoming QR
HLFG's Result
HLFG's Financial Summary
View:
Show?
Quarter Result
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Revenue 1,383,165 1,319,869 1,386,355 1,366,015 1,278,752 1,273,064 1,225,583 8.38%
PBT 929,106 870,627 942,769 924,728 840,461 768,126 763,815 13.93%
Tax -159,499 -177,471 -181,273 -174,941 -150,374 -325,672 -136,488 10.93%
NP 769,607 693,156 761,496 749,787 690,087 442,454 627,327 14.58%
-
NP to SH 505,695 454,290 502,557 495,343 455,252 258,794 418,746 13.39%
-
Tax Rate 17.17% 20.38% 19.23% 18.92% 17.89% 42.40% 17.87% -
Total Cost 613,558 626,713 624,859 616,228 588,665 830,610 598,256 1.69%
-
Net Worth 18,182,568 17,796,897 17,622,136 17,327,505 17,109,476 16,661,945 16,616,044 6.18%
Dividend
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Div 148,849 - 308,759 - 149,177 - 286,879 -35.40%
Div Payout % 29.43% - 61.44% - 32.77% - 68.51% -
Equity
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Net Worth 18,182,568 17,796,897 17,622,136 17,327,505 17,109,476 16,661,945 16,616,044 6.18%
NOSH 1,147,516 1,147,516 1,147,516 1,147,516 1,147,516 1,147,516 1,147,516 0.00%
Ratio Analysis
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
NP Margin 55.64% 52.52% 54.93% 54.89% 53.97% 34.76% 51.19% -
ROE 2.78% 2.55% 2.85% 2.86% 2.66% 1.55% 2.52% -
Per Share
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
RPS 120.80 115.32 121.23 119.04 111.44 110.94 106.80 8.55%
EPS 44.20 39.70 43.90 43.30 39.80 22.60 36.60 13.39%
DPS 13.00 0.00 27.00 0.00 13.00 0.00 25.00 -35.30%
NAPS 15.88 15.55 15.41 15.10 14.91 14.52 14.48 6.34%
Adjusted Per Share Value based on latest NOSH - 1,147,516
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
RPS 120.54 115.02 120.81 119.04 111.44 110.94 106.80 8.39%
EPS 44.07 39.59 43.80 43.30 39.80 22.60 36.60 13.16%
DPS 12.97 0.00 26.91 0.00 13.00 0.00 25.00 -35.40%
NAPS 15.8451 15.509 15.3568 15.10 14.91 14.52 14.48 6.18%
Price Multiplier on Financial Quarter End Date
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Date 28/09/18 29/06/18 30/03/18 29/12/17 29/09/17 30/06/17 31/03/17 -
Price 19.30 18.00 19.26 17.88 16.60 16.80 15.90 -
P/RPS 15.98 15.61 15.89 15.02 14.90 15.14 14.89 4.81%
P/EPS 43.70 45.35 43.83 41.42 41.84 74.49 43.57 0.19%
EY 2.29 2.21 2.28 2.41 2.39 1.34 2.30 -0.28%
DY 0.67 0.00 1.40 0.00 0.78 0.00 1.57 -43.28%
P/NAPS 1.22 1.16 1.25 1.18 1.11 1.16 1.10 7.13%
Price Multiplier on Announcement Date
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Date 28/11/18 28/08/18 30/05/18 26/02/18 30/11/17 24/08/17 29/05/17 -
Price 19.18 18.60 18.50 18.46 16.06 16.70 16.42 -
P/RPS 15.88 16.13 15.26 15.51 14.41 15.05 15.37 2.19%
P/EPS 43.43 46.86 42.10 42.76 40.48 74.05 45.00 -2.33%
EY 2.30 2.13 2.38 2.34 2.47 1.35 2.22 2.38%
DY 0.68 0.00 1.46 0.00 0.81 0.00 1.52 -41.47%
P/NAPS 1.21 1.20 1.20 1.22 1.08 1.15 1.13 4.66%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment